Explore more publications!
Healthcare Journal of Oregon
Submit Press Release

Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 27, 2025

Aurora Spine Launches New Biologics Portfolio
October 27, 2025

Aurora Spine Launches New Biologics Portfolio

Indeterminate GlobeNewswire
Elixir Medical anuncia resultados clínicos recientes y significativos sobre el Bioadaptador DynamX® que demuestran una reducción de casi el 50 % en las tasas de acontecimiento coronarios en comparación con el tratamiento de referencia actua
October 27, 2025

Elixir Medical anuncia resultados clínicos recientes y significativos sobre el Bioadaptador DynamX® que demuestran una reducción de casi el 50 % en las tasas de acontecimiento coronarios en comparación con el tratamiento de referencia actua

Indeterminate GlobeNewswire
Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX® Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care
October 27, 2025

Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX® Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care

Indeterminate GlobeNewswire
Elixir Medical annonce de nouveaux résultats cliniques significatifs pour le DynamX® Bioadaptor, démontrant une réduction de près de 50 % des taux d’événements coronariens par rapport à la norme actuelle de soins ICP
October 27, 2025

Elixir Medical annonce de nouveaux résultats cliniques significatifs pour le DynamX® Bioadaptor, démontrant une réduction de près de 50 % des taux d’événements coronariens par rapport à la norme actuelle de soins ICP

Indeterminate GlobeNewswire
Elixir Medical ogłasza przełomowe wyniki badań klinicznych DynamX® Bioadaptor – wskazujące na niemal 50% redukcję częstości występowania nieporządanych incydentów wieńcowych w porównaniu do obecnego standardu leczenia PCI
October 27, 2025

Elixir Medical ogłasza przełomowe wyniki badań klinicznych DynamX® Bioadaptor – wskazujące na niemal 50% redukcję częstości występowania nieporządanych incydentów wieńcowych w porównaniu do obecnego standardu leczenia PCI

Indeterminate GlobeNewswire
Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences
October 27, 2025

Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences

Indeterminate GlobeNewswire
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
October 27, 2025

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

Indeterminate GlobeNewswire
Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025
October 27, 2025

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

Indeterminate GlobeNewswire
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
October 27, 2025

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

Indeterminate GlobeNewswire
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
October 27, 2025

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

Indeterminate GlobeNewswire
Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025
October 27, 2025

Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

Indeterminate GlobeNewswire
IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025
October 27, 2025

IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025

Indeterminate GlobeNewswire
Arcutis to Present at Upcoming Investor Conferences
October 27, 2025

Arcutis to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Axis Integrated Mental Health Acquires Best Mind to Combat Colorado’s Mental Health Crisis
October 27, 2025

Axis Integrated Mental Health Acquires Best Mind to Combat Colorado’s Mental Health Crisis

Indeterminate GlobeNewswire
AI’s Transformative Role in Global Markets Highlighted in BCC Pulse Reports
October 27, 2025

AI’s Transformative Role in Global Markets Highlighted in BCC Pulse Reports

Indeterminate GlobeNewswire
Fungushead Launches Veteran ‘Angel’s Wing Scholarship’ and Reaffirms Microscopy-Only Standards as California Accelerates Psychedelic Research (AB 1103)
October 27, 2025

Fungushead Launches Veteran ‘Angel’s Wing Scholarship’ and Reaffirms Microscopy-Only Standards as California Accelerates Psychedelic Research (AB 1103)

Indeterminate GlobeNewswire
Health Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer’s Disease
October 27, 2025

Health Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer’s Disease

Indeterminate GlobeNewswire
Health legislation update brings breast cancer care into the modern age
October 27, 2025

Health legislation update brings breast cancer care into the modern age

Indeterminate GlobeNewswire
LifeLabs Care Packages Bring Comfort to Children with Cancer at POGO Satellite Clinics
October 27, 2025

LifeLabs Care Packages Bring Comfort to Children with Cancer at POGO Satellite Clinics

Indeterminate GlobeNewswire
Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration
October 27, 2025

Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions